Loading…
Loading…
| # | Company | Amount | Status |
|---|---|---|---|
| 1 | ₹5.0 LAdmitted-Finance | ₹5.0 L | Admitted-Finance |
| 2 | ₹6.5 LAdmitted-Finance | ₹6.5 L | Admitted-Finance |
| 3 | ₹11.0 LAdmitted-Finance | ₹11.0 L | Admitted-Finance |
| 4 | ₹11.3 LAdmitted-Finance 2ND FLOOR 201 SIMANDHAR ESTATE NR C U SHAH COLLEGE OPP SAKAR 3 INCOME TAX ASHRAM ROAD AHMEDABAD GUJARAT | ₹11.3 L | Admitted-Finance |
| 5 | ₹16.0 LAdmitted-Finance | ₹16.0 L | Admitted-Finance |
| Sl No | Description | Qty | Unit | ARHAMPHARMA | K.R.MEHTA & CO | Gajanand Enterprise | JIVANDHARA PHARMA PVT LTD | THE CHEMIST |
|---|---|---|---|---|---|---|---|---|
| 1.00Medicine | ||||||||
| 1.01 | Tab. Albendazole 400mg (Chewable) | 3,48,444 | Nos | 6,51,590.28 ₹6,51,590.28 | 11,32,443 ₹11,32,443 | 5,01,759.36 ₹5,01,759.36 Lowest | 15,99,357.96 ₹15,99,357.96 | 10,97,598.6 ₹10,97,598.6 |
Tender Value
Refer Docs
EMD Value
₹34,408
Closing Date
6 Aug 2025, 10:00 amClosed
I/c CPB DNHDD
2nd floor, CHC campus, Moti Daman, Daman
Purchase of Tab. Albendazole 400mg (Chewable) for NHM department DNH DD
2025_DAMAN_4377_1
CPB/DNHDD/Albendazole Tablet/2025 26/113
Open Tender
Medicines
Item Wise
3 days
2nd floor, CHC campus, Moti Daman
Please refer Tender documents.
2 documents required · 2 mandatory
₹500
The Mission Director NHM Daman
₹34,408
Yes
1 Sept 2025
2 Aug 2025
6 Aug 2025
2 Aug 2025
6 Aug 2025
2 Aug 2025
Medicine
Tab. Albendazole 400mg (Chewable)
stage.html
html • 0.03 MB
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .